興民智通(002355.SZ):目前用於無人駕駛領域的產品包括車輛測試和監控使用的道路試驗終端產品
格隆匯6月27日丨興民智通(002355.SZ)近期在業績説明會上表示,公司目前用於無人駕駛領域的產品包括車輛測試和監控使用的道路試驗終端產品;用於 L3 及以上得自動駕駛使用的帶 v2x 功能得車載終端;5G+V2X TBOX 車載終端;C-V2X ITS 軟件協議棧和應用軟件;用於車路協同使用的 RSU 路側設備等。公司會根據行業發展情況、客户需求,結合自身研發生產能力來決定後續的投入計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.